Current filters:  
Healthcare
Life Sciences, Biotechnology & Nanotechnology
Canada
Oyen Wiggs Green & Mutala LLP
An application for leave to appeal the decision in Apotex Inc. v. Janssen Inc., 2024 FCA 9 has been filed by Apotex in the Supreme Court of Canada (SCC).
Blake, Cassels & Graydon LLP
Welcome to the March edition of Blakes upRound, a regular publication from the Blakes Emerging Companies & Venture Capital (EC&VC) group...
Fasken
On January 26, Health Canada issued a notice clarifying how a drug's "dormant" status on the drug product database may affect whether that drug...
Fasken
The federal Parliament tabled Bill C-64, An Act respecting pharmacare (the "Bill"), on February 29, 2024. The Bill outlines the first phase of the federal government's...
Fasken (French)
Le 26 janvier, Santé Canada a publié un avis précisant comment l'état « dormant » d'un médicament dans la base de données sur les produits pharmaceutiques...
China
Rouse
The Patent Re-examination Board of China's National Intellectual Property Administration (PRB) recently issued a decision to invalidate two "orange book" patents owned by AbbVie.
Denmark
Plesner
From 1 April 2024, pharmaceutical companies must agree on an application date with the Danish Medicines Council's secretariat when they want an assessment of a new medicinal product.
India
Khurana and Khurana
Intellectual property is crucial in the cutting-edge world, where thoughts, developments, and imaginative works hold tremendous worth.
S&A Law Offices
In the realm of branding, suggestive exert a unique power, entrancing consumers' imaginations while leaving room for interpretations.
S&A Law Offices
The idea that previously discovered chemicals and compositions may be used to discover novel functions, capacities, or medicinal applications is certainly intriguing.
Ireland
Marks & Clerk
With the Cheltenham Festival grabbing the majority of the sporting headlines this week, it's great to also see TrojanTrack making the final of the One-Zero start-up competition...
Scotland
Marks & Clerk
Bioeconomy Week Scotland 2024 hosted by Industrial Biotechnology Innovation Centre (IBioIC) is taking place between 11 and 15 March 2024.
South Africa
Adams & Adams
On Friday, February 2, 2024, Mr. Denis BOHOUSSOU, Director General of OAPI, welcomed a delegation from the Heads of the "Health and Globalization, Standards, Policies, Market"...
Switzerland
Kellerhals Carrard
What are important changes in regulation and what is to be expected from the markets in 2024? The co-heads of Kellerhals Carrard's Life Sciences Practice Group share their perspective on key developments.
Turkey
Gun + Partners
1262 sayılı İspençiyari ve Tıbbi Müstahzarlar Kanunu ("1262 sayılı Kanun") ile 3359 sayılı Sağlık Hizmetleri Temel Kanunu'nundaki ("3359 sayılı Kanun") klinik araştırma hükümlerinde değişiklik...
Gun + Partners
Named Patient Program ("NPP") is one of the exceptional pharmaceutical importation regimes for products that are not authorized or authorized...
Gun + Partners
On 1 March 2024, the Omnibus Law Amending Certain Laws and Decree Law No. 663 (the "Omnibus Law"), which amends certain provisions of the Law No. 1262 on Pharmaceuticals...
Esin Attorney Partnership
The Turkish Pharmaceuticals and Medical Devices Authority ("TİTCK") recently amended: i) the Decree on the Pricing of Pharmaceuticals, ii) the Guideline on the Classification...
Esin Attorney Partnership
Türkiye İlaç ve Tıbbi Cihaz Kurumu ("Kurum") geçtiğimiz haftalarda i) Beşeri Tıbbi Ürünlerin Fiyatlandırılmasına Dair Karar, ii)...
Gun + Partners
Yabancı ilaç markaları kural olarak o şirketlerin kurulduğu ülkelerdeki firmalar adına kayıtlıdır ve marka koruma işlemleri o firmalar tarafından yönetilir.
FREE News Alerts
Sign Up for our free News Alerts - All the latest articles on your chosen topics condensed into a free bi-weekly email.
Popular Contributors
Upcoming Events
Mondaq Social Media